Adult atrial septal defect (chronic ACHD)

Adult aortic coarctation (native + repaired, chronic ACHD)

Ebstein anomaly of the tricuspid valve (adult, chronic ACHD)

Eisenmenger syndrome (chronic ACHD — PAH-CHD severe end)

Adult Fontan circulation (single-ventricle palliation, chronic ACHD)

Repaired Tetralogy of Fallot (adult, chronic ACHD)

Adult ventricular septal defect (chronic ACHD)

Acute HF — acute decompensation on chronic HF

Acute HF — alcoholic cardiomyopathy

ADHF in cardiac amyloidosis (ATTR-CM and AL)

Acute HF — Type-1 cardiorenal syndrome (ADHF + AKI)

Acute HF — Immune checkpoint inhibitor (ICI) cardiotoxicity / fulminant myocarditis

Acute HF — Chemotherapy / cancer therapy-induced cardiomyopathy (CTRCD)

Acute HF — constrictive pericarditis decompensation

Acute decompensated heart failure

Acute heart failure — de novo (first presentation)

Acute HF — diabetic cardiomyopathy

Acute HF — frail elderly (age ≥80, CFS ≥6)

Acute HF — HD-dependent ESRD

Acute HF — eosinophilic myocarditis decompensation (non-shock)

ADHF in Fabry cardiomyopathy

Hypertrophic cardiomyopathy with acute decompensation

Acute HF — hemochromatosis / iron-overload cardiomyopathy

Acute HF — high-output from severe anemia (Hb <7)

Acute HF — Iatrogenic hypothyroid (post-thyroidectomy / post-RAI / over-treated thionamide)

Acute HF — Infusion-reaction cardiotoxicity (mAb / CAR-T CRS / transfusion reaction / contrast)

ADHF in SLE myocarditis

Acute HF — Peripartum cardiomyopathy (PPCM)

Acute HF — RV-predominant decompensated HF

Acute HF — sepsis-induced cardiomyopathy (SICM)

Acute HF — Takotsubo (apical ballooning) decompensation (non-shock)

Acute HF — thyrotoxicosis-induced (high-output)

ADHF in cardiac transplant recipient (CAV / ACR / AMR)

Acute HF — viral cardiomyopathy / myocarditis decompensation (non-shock)

Acute decompensated HF complicated by atrial fibrillation with rapid ventricular response

ADHF complicated by cardiogenic shock (composite)

Atrial fibrillation (rate / rhythm / anticoagulation)

AL (light-chain) cardiac amyloidosis — chronic (cardiology arm)

Aortic stenosis (calcific + bicuspid + rheumatic; high-gradient & low-flow/low-gradient)

Aortic dissection (Stanford A / B + IMH / PAU)

Chronic aortic regurgitation

Low-flow low-gradient severe aortic stenosis (classical + paradoxical)

Mixed aortic valve disease (combined AS + AR)

Arrhythmogenic RV / biventricular cardiomyopathy (ARVC/ALVC, chronic)

Chronic coronary / ASCVD secondary prevention

Atrial flutter / IART in adult congenital heart disease (ACHD)

Alcohol-related atrial flutter ("Holiday Heart Syndrome")

Atrial flutter in cardiac amyloidosis (ATTR-CM and AL)

Atrial flutter in adult unrepaired/late-repaired atrial septal defect (RA volume overload → CTI macroreentry)

Atypical / scar-mediated / left atrial flutter

Refractory atrial flutter — cardioversion-failed

Cocaine-induced atrial flutter (sympathetic + α-adrenergic + Na-channel substrate)

Atrial flutter in the long-term endurance athlete

Atrial flutter / atrial tachycardia — post-cardiac-surgery (POAF)

Iatrogenic post-PVI atypical LA flutter (gap-related macroreentry)

Thyrotoxicosis-precipitated atrial flutter

Typical (CTI-dependent) atrial flutter

Atrial flutter (typical and atypical)

Atrial flutter precipitating cardiogenic shock (AFL with RVR + low-output state)

Atrial flutter with concurrent acute pulmonary embolism

Atrial flutter complicated by acute embolic stroke

Pre-excited atrial flutter (WPW) — DCCV / procainamide; AV-nodal blockers ABSOLUTELY contraindicated

Transthyretin amyloid cardiomyopathy (ATTR-CM, ATTRv + ATTRwt)

Brady-tachy syndrome / sick sinus syndrome

Brugada syndrome (chronic ambulatory — SCD risk stratification)

Cardiac sarcoidosis (chronic — immunosuppression + arrhythmic protection)

Cardiac tamponade — Type A aortic dissection-related (hemopericardium)

Cardiac tamponade — blunt chest trauma (MVA, fall, sternal blow)

Cardiac tamponade — chylopericardium (chylous pericardial effusion)

Cardiac tamponade

Cardiac tamponade — Dressler syndrome (post-cardiac-injury syndrome)

Cardiac tamponade — effusive-constrictive pericarditis (Sagristà-Sauleda syndrome)

Cardiac tamponade — HIV-related pericardial effusion

Cardiac tamponade — malignant pericardial effusion

Cardiac tamponade — myxedema-related pericardial effusion

Cardiac tamponade — post-procedural / hemopericardium / iatrogenic

Cardiac tamponade — post-RF ablation iatrogenic (PVI / atypical-flutter / steam-pop)

Cardiac tamponade — post-TAVR (transcatheter aortic valve replacement)

Cardiac tamponade — purulent bacterial pericarditis

Cardiac tamponade — radiation-induced pericardial disease

Cardiac tamponade — late post-radiation effusive-constrictive pericarditis

Cardiac tamponade — tuberculous pericarditis

Cardiac tamponade — uremic pericardial effusion

Cardio-obstetric: pre-pregnancy risk + pregnancy cardiac management (cross-system)

Cardio-oncology cardiotoxicity surveillance & management (chronic, cross-system)

Pulmonary hypertension due to left heart disease (Group 2 PH, cross-system)

Cardiogenic shock — acromegaly-induced cardiomyopathy

Cardiogenic shock — acute severe aortic regurgitation

Cardiogenic shock — acute severe mitral regurgitation

Cardiogenic shock — acute severe MR from infective endocarditis

Cardiogenic shock — after non-cardiac surgery (perioperative)

Cardiogenic shock — amniotic fluid embolism (AFE)

Cardiogenic shock — cardiac amyloidosis (ATTR-CM and AL)

Cardiogenic shock — anthracycline-induced cardiomyopathy with shock physiology

Cardiogenic shock — bacterial myocarditis (Staph, Strep, diphtheria, TB, meningococcal)

Cardiogenic shock — Beta-blocker overdose (HIE-first toxicologic CS)

Cardiogenic shock — Brugada syndrome electrical storm

Cardiogenic shock — Calcium channel blocker overdose (HIE-first toxicologic CS)

Cardiogenic shock (SCAI A–E)

Cardiogenic shock — COVID-19-associated myocarditis (infection or post-mRNA-vaccine)

Cardiogenic shock — Eosinophilic myocarditis (hypersensitivity / parasitic / HES / EGPA)

Cardiogenic shock — giant cell myocarditis (GCM)

Cardiogenic shock — Long-QT torsades de pointes (TdP) electrical storm

Cardiogenic shock / high-grade AV block — Lyme carditis

Cardiogenic shock — PE-related (massive PE with RV failure)

Cardiogenic shock — peripartum cardiomyopathy (PPCM, severe)

Cardiogenic shock — Post-CABG

Cardiogenic shock — Post non-CABG cardiac surgery (valve / transplant / complex)

Cardiogenic shock — Post pacemaker / ICD / CRT implantation

Cardiogenic shock — post-hematopoietic-stem-cell-transplant recipient

Cardiogenic shock — RV-predominant

Cardiogenic shock — SCAI Stage D (deteriorating)

Cardiogenic shock — SCAI Stage E (extremis / refractory)

Cardiogenic shock — septic-mixed (SICM + distributive overlap)

Cardiogenic shock — Takotsubo with dynamic LVOT obstruction (SAM-mediated)

Cardiogenic shock — Takotsubo (stress) cardiomyopathy

Cardiogenic shock — fulminant viral / immune myocarditis

Chronic cardiorenal syndrome (CRS type 2/4, cross-system)

Catecholaminergic polymorphic VT (CPVT, chronic)

Genetic / familial dilated cardiomyopathy (LMNA/FLNC/TTN/RBM20/DSP, chronic)

Antiphospholipid syndrome (APS) DVT — warfarin preferred, DOAC avoided

DVT/VTE in Behçet's disease (variable-vessel vasculitis)

Cancer-associated DVT (CAT)

Incidental DVT on cancer-staging imaging

Deep vein thrombosis

Distal DVT (isolated calf vein)

Factor V Leiden thrombophilia DVT (heterozygous or homozygous)

DVT/VTE with Heparin-Induced Thrombocytopenia (HIT/HITT)

DVT in JAK2-V617F-positive myeloproliferative neoplasm (PV / ET / PMF)

DVT from prolonged immobilization (post-stroke / SCI / post-arthroplasty / prolonged ICU)

May-Thurner syndrome (left iliac vein compression DVT)

Nephrotic-syndrome DVT (urinary AT-III/protein S loss; LMWH preferred over DOAC)

DVT in paroxysmal nocturnal hemoglobinuria (PNH)

Post-orthopedic-arthroplasty DVT (post-THA/TKA/hip-fracture; ASA vs DOAC vs LMWH per AAOS 2025 + ACCP)

DVT during pregnancy / postpartum

Proximal DVT (iliofemoral / popliteal)

Recurrent DVT on therapeutic anticoagulation (treatment failure)

Spinal-cord-injury DVT/VTE (highest-risk; LMWH within 24-72 h, IPC adjunct, no routine IVC filter)

DVT/VTE in thromboangiitis obliterans (Buerger's disease)

Travel-associated DVT (long-haul flight or train >4 h)

Upper-extremity DVT (subclavian / axillary / brachial)

Warfarin-induced skin necrosis (protein C/S deficiency unmasking)

DVT with coexistent pulmonary embolism (combined VTE)

Heart failure in the frail older adult (chronic, sub-population)

Hypertrophic cardiomyopathy (chronic management)

Heart failure with improved EF (HFimpEF — recovered, prior LVEF ≤40)

Heart failure (chronic, GDMT titration)

Heart failure with mildly reduced EF (HFmrEF, LVEF 41–49)

Heart failure with preserved EF (HFpEF, LVEF ≥50)

Heart failure with reduced EF (HFrEF, LVEF ≤40)

Hypertension (chronic management)

Resistant hypertension (≥3 meds at max + diuretic)

Acute aortic aneurysm + malperfusion in hypertensive emergency (anti-impulse + emergent endovascular/open repair)

Hypertensive emergency with acute (flash) pulmonary edema

Acute renovascular flash pulmonary edema (Pickering syndrome)

Amphetamine / stimulant WITHDRAWAL hypertensive crisis (rebound HTN + autonomic instability + tachy + diaphoresis + tremor + agitation/depression overlap 6-72 h after abrupt cessation of chronic stimulant therapy or use)

Aortic dissection in hypertensive crisis (HR + dP/dt FIRST, then SBP)

Autonomic dysreflexia (SCI ≥T6; remove trigger FIRST, short-acting titratable drugs second)

Clonidine / α2-agonist withdrawal hypertensive crisis (rebound NE surge HTN + tachy + diaphoresis + tremor 18-72 h after abrupt cessation of clonidine, methyldopa, dexmedetomidine, or guanfacine)

Cocaine / sympathomimetic hypertensive crisis (alpha-driven HTN + tachycardia + coronary vasospasm)

Hypertensive emergency

Cushing syndrome HTN crisis (cortisol-excess–driven severe HTN with hypokalemic alkalosis)

HELLP syndrome with severe HTN + eclampsia overlap (peripartum HTN crisis)

Severe pre-eclampsia / eclampsia (peripartum hypertensive crisis)

Hypertensive encephalopathy (HTN crisis with cerebral edema / AMS / papilledema)

Glucocorticoid-induced hypertensive crisis (severe HTN driven by high-dose prednisone >20 mg/d, methylprednisolone, or hydrocortisone via mineralocorticoid receptor activation, Na+ retention, RAAS upregulation, and vascular sensitization — fluorinated dexamethasone less implicated)

MAOI–tyramine hypertensive crisis ("cheese effect" — severe occipital headache + HTN crisis + tachycardia + diaphoresis after MAOI + tyramine-rich food or sympathomimetic exposure)

Methamphetamine / amphetamine-derivative hypertensive crisis (sustained ~12-24 h α-adrenergic + dopaminergic + serotonergic crisis with hyperthermia + agitation + meth-induced cardiomyopathy risk)

NSAID-induced hypertensive crisis (severe HTN driven by COX-1/COX-2 inhibition from indomethacin, ketorolac, naproxen, ibuprofen, diclofenac, or celecoxib — most severe in CKD, HF, elderly, cirrhosis, or with concurrent ACEi/ARB/diuretic via "triple whammy" mechanism causing AKI; aspirin LESS implicated at low cardiovascular dose 81 mg/d)

Obesity + obstructive sleep apnea (OSA) hypertensive emergency (resistant-HTN phenotype with sympathetic + RAAS overdrive; CPAP + weight loss + MRA central to long-term control)

Pheochromocytoma / paraganglioma crisis (catecholamine-driven episodic HTN crisis)

Hypertensive emergency in kidney transplant recipient (CNI / rejection / TRAS / native disease recurrence)

Hypertensive emergency in acute ischemic stroke (autoregulation-aware BP target by reperfusion eligibility)

Primary aldosteronism (Conn / BAH) HTN crisis (autonomous aldosterone–driven severe HTN with hypokalemic alkalosis)

Pulmonary hypertension crisis in scleroderma (PAH-SSc WHO Group 1 — RV failure with shock)

Scleroderma renal crisis (SRC) — renin-driven HTN + AKI + MAHA in systemic sclerosis

Serotonin syndrome hypertensive crisis (autonomic instability + neuromuscular hyperactivity + altered mental status + HTN crisis ± hyperthermia)

Thyroid storm with HTN-emergency overlap (BWPS ≥45 + AFib-RVR + HF + AMS)

Idiopathic pulmonary arterial hypertension (Group 1 PAH)

Infective endocarditis (Duke-ISCVID)

Dyslipidemia / lipid management

Congenital Long QT Syndrome (chronic — genotype-driven)

LV non-compaction / hypertrabeculation cardiomyopathy (chronic)

Mitral stenosis (rheumatic + degenerative)

Chronic primary (degenerative) mitral regurgitation

Chronic secondary (functional) mitral regurgitation

Neurally-Mediated Reflex Syncope (vasovagal / situational / carotid sinus)

NSTEMI in active-cancer patient (cardio-oncology bleeding-risk balance)

Cocaine-induced NSTEMI (sympathetic crisis + vasospasm)

NSTEMI / NSTE-ACS (UA + NSTEMI)

NSTEMI — diabetic silent / atypical (autonomic neuropathy; anginal-equivalent presentation)

NSTEMI in dialysis/ESKD — troponin delta (not absolute) drives diagnosis; renally-reconciled therapy

NSTEMI in hypertrophic cardiomyopathy — microvascular ischemia + supply-demand mismatch

High-risk NSTE-ACS (cath ≤24 h)

Intermediate-risk NSTE-ACS (cath 25-72 h)

MINOCA — MI with Non-Obstructive Coronary Arteries

Octogenarian NSTE-ACS — conservative strategy

NSTEMI peri-operative — within 30 days post-CABG (UDMI Type 5 NSTEMI variant)

Post-PCI stent thrombosis (NSTEMI presentation)

NSTEMI in heart-transplant recipient — cardiac allograft vasculopathy (CAV)-driven

Prinzmetal / vasospastic angina presenting as NSTE-ACS

NSTEMI from spontaneous coronary artery dissection (SCAD)

Type-2 MI (demand ischemia, no plaque rupture)

Pediatric cardiomyopathy (chronic, sub-population)

Pericarditis (acute / recurrent / IMPS)

Post-cardiac-arrest care — arrhythmogenic right-ventricular cardiomyopathy (ARVC; PKP2 / DSP desmosomal; exercise-induced VT/VF arrest)

Post-cardiac-arrest care — Brugada syndrome channelopathy (SCN5A type 1 ECG; sleep / fever-triggered VF)

Post-cardiac-arrest care — cocaine-related arrest (sympathomimetic + Na-channel blockade)

Post-cardiac-arrest care — commotio cordis (R-on-T blunt chest impact)

Post-cardiac-arrest care (cardiology-driven, ischemic-OHCA pathway)

Post-cardiac-arrest care — CPVT channelopathy (RYR2 / CASQ2; exercise- or emotion-triggered bidirectional VT → VF arrest)

Post-cardiac-arrest care — drowning-induced cardiac arrest

Post-cardiac-arrest care — electrical-injury-induced arrest

Post-cardiac-arrest care — hypothermic cardiac arrest

Post-cardiac-arrest care — congenital long-QT channelopathy (KCNQ1 / KCNH2 / SCN5A) with TdP-arrest

Post-cardiac-arrest care — initial non-shockable rhythm (PEA/asystole)

Post-cardiac-arrest care — opioid-overdose-induced arrest

Post-cardiac-arrest care — peripartum maternal arrest

PE-related cardiac arrest — peri-arrest thrombolysis + prolonged CPR; embolectomy/ECPR if lysis fails

Post-cardiac-arrest care — initial shockable rhythm (VF/pVT)

Post-cardiac-arrest care — TTM protocol (cooling, rewarm, fever prevention)

Post-cardiac-arrest care — tricyclic antidepressant (TCA) overdose

Prosthetic heart valve — chronic management

Restrictive cardiomyopathy (chronic — etiology hunt + RCM-vs-CP pivot)

Anterior wall STEMI (LAD culprit)

STEMI — antiphospholipid syndrome related (arterial APS thrombosis)

STEMI — Behçet-disease-associated coronary vasculitis (variable-vessel vasculitis with aneurysms + thrombosis)

Cocaine-induced STEMI (sympathetic crisis + vasospasm + thrombosis)

STEMI / OMI (acute coronary syndrome)

STEMI in pregnancy — non-SCAD etiology (atherosclerotic / embolic / thrombotic)

Inferior wall STEMI (RCA / LCx culprit)

STEMI from prior Kawasaki disease coronary aneurysm / stenosis

Late-presenter STEMI (>12 h after symptom onset)

Left main coronary artery (LMCA) STEMI-equivalent

STEMI — SLE-associated coronary vasculitis (immune-complex inflammation + premature CAD)

STEMI post-PCI no-reflow phenomenon (TIMI ≤2 despite patent epicardial vessel)

STEMI in prior-CABG patient (graft failure or native progression)

Isolated posterior wall STEMI (LCx / PDA culprit)

Recurrent STEMI in patient with prior MI history

Radiation-induced STEMI (post chest/mediastinal XRT)

Right-ventricular extension STEMI (proximal RCA)

STEMI from spontaneous coronary artery dissection (SCAD)

STEMI in sickle cell disease (vaso-occlusive / microvascular)

STEMI in cardiac transplant recipient (CAV-driven)

STEMI complicated by ventricular electrical storm (≥3 sustained VT/VF/24 h)

STEMI complicated by mechanical complication (PMR / VSR / free-wall rupture)

STEMI complicated by out-of-hospital cardiac arrest with ROSC

Transient ischemic attack (TIA)

Chronic tricuspid regurgitation

Valvular heart disease (AS / AR / MR / MS)

Wolff-Parkinson-White / ventricular preexcitation (chronic ablation pathway)

Preoperative Cardiac Risk Evaluation (Noncardiac Surgery)

Allergic Bronchopulmonary Aspergillosis (ABPA)

Asthma–COPD Overlap (ACO) — GINA/GOLD 2026 ICS-foundation

Acute Respiratory Distress Syndrome

Aspiration Pneumonia

Asthma (chronic stepwise + acute exacerbation)

Atypical Pneumonia (Mycoplasma / Chlamydophila / Legionella / psittacosis / Q fever)

Bronchiectasis (non-CF — chronic + exacerbation)

Community-Acquired Pneumonia

COPD (chronic GOLD ABE + exacerbation)

Connective-tissue-disease-associated ILD (CTD-ILD / IPAF)

Pleural Infection / Empyema

Hospital-Acquired & Ventilator-Associated Pneumonia (HAP / VAP, non-COVID)

Hypersensitivity pneumonitis (acute + chronic-fibrotic)

Idiopathic pulmonary fibrosis (IPF)

Massive (Life-Threatening) Hemoptysis (acute airway emergency)

Obstructive sleep apnea (adult chronic — AASM dx + PAP-first therapy ladder)

Pneumocystis (jirovecii) Pneumonia

Pulmonary Embolism (acute + extended)

Pleural Effusion

Pneumothorax (PSP / SSP / tension / traumatic)

Pulmonary hypertension Groups 2–5 (non-PAH)

Sarcoidosis (pulmonary + extrapulmonary)

Acute Appendicitis

Acute Cholangitis

Acute Cholecystitis

Acute Infectious Gastroenteritis / Acute Diarrhoea (viral, bacterial incl. invasive/inflammatory, traveller's, toxin food poisoning, C. difficile pointer) — adult + pediatric

Acute Pancreatitis

Clostridioides difficile Infection

Crohn's Disease

Acute Colonic Diverticulitis (uncomplicated vs complicated — modified Hinchey) + post-recovery management

Eosinophilic Esophagitis

Functional Dyspepsia (Rome IV; postprandial distress syndrome / epigastric pain syndrome / overlap; H. pylori-associated dyspepsia; FD-GERD/IBS overlap)

Gastroparesis

GERD (chronic, empiric-to-maintenance)

Hepatocellular Carcinoma (HCC, BCLC-staged)

Haemorrhoidal Disease & Common Benign Anorectal Conditions (internal/external haemorrhoids Goligher I–IV, thrombosed external haemorrhoid, acute anal fissure, perianal abscess pointer) — rectal bleeding NOT assumed benign

Hepatic Encephalopathy (acute episode + chronic maintenance)

Irritable Bowel Syndrome (Rome IV; IBS-D / IBS-C / IBS-M / IBS-U; post-infectious IBS)

Lower GI Bleeding

MASLD / MASH (formerly NAFLD/NASH)

Peptic Ulcer Disease

Small Bowel Obstruction

Upper GI Bleeding

Ulcerative Colitis

Acute variceal hemorrhage (esophageal / gastric / ectopic)

Cirrhosis (chronic, compensated + decompensated)

Hepatorenal Syndrome (HRS-AKI)

Acute Liver Failure

Severe Alcoholic Hepatitis

Spontaneous Bacterial Peritonitis

Chronic Hepatitis C

Acute Kidney Injury (KDIGO)

Chronic Kidney Disease (KDIGO G/A staging + GDMT)

Acute Kidney Injury — Intrinsic ATN Mechanism

Acute Kidney Injury — Post-renal (Obstructive) Mechanism

Acute Kidney Injury — Pre-renal Mechanism

Acute Kidney Injury

Cardiorenal Syndromes (Ronco 1-5)

CKD Progression & Management (G1-G5 + ACR stratified)

Contrast-Induced / Contrast-Associated AKI (CI-AKI / CA-AKI)

Diabetic Kidney Disease (DKD)

Focal Segmental Glomerulosclerosis

Hepatorenal Syndrome (HRS-AKI)

Hypertensive Nephrosclerosis (HTN-CKD)

IgA Nephropathy

Lupus Nephritis (ISN/RPS Classes I-VI)

Membranous Nephropathy

Minimal Change Disease

Rapidly Progressive Glomerulonephritis

Hyperkalemia (syndrome aggregator)

Hyponatremia (syndrome aggregator)

Acute Traumatic Spinal Cord Injury (SCI)

Acute Vestibular Syndrome (HINTS pivot for central vs peripheral)

Acute Disseminated Encephalomyelitis (ADEM)

Alzheimer Disease (outpatient + biomarker era)

Bell Palsy (idiopathic peripheral facial palsy)

Brain Abscess (Pyogenic)

Cauda Equina Syndrome

Cerebral Venous Sinus Thrombosis (CVST)

Cluster Headache

Delirium (inpatient/ICU)

Anti-LGI1 Encephalitis

Anti-NMDA Receptor Encephalitis

Other Autoimmune Encephalitis (surface + intracellular AB)

HSV Encephalitis (acute)

First Unprovoked / New-Onset Seizure Evaluation (adult)

Guillain-Barré Syndrome — AIDP (classic demyelinating)

Guillain-Barré Syndrome — AMAN (acute motor axonal)

Miller-Fisher Syndrome (GBS variant)

Guillain-Barré Syndrome

Intracerebral Hemorrhage — Cerebellar (emergent decompression)

Intracerebral Hemorrhage — Deep (hypertensive)

Intracerebral Hemorrhage — Lobar (CAA-suspected)

Intracerebral Hemorrhage

Idiopathic Intracranial Hypertension (Pseudotumor Cerebri)

Acute Ischaemic Stroke

Myasthenic Crisis

Migraine

Myelin Oligodendrocyte Glycoprotein-Antibody Associated Disease (MOGAD)

Multiple Sclerosis Flare

Primary Progressive Multiple Sclerosis

Relapsing-Remitting Multiple Sclerosis (chronic DMT)

Secondary Progressive Multiple Sclerosis

Neuromyelitis Optica Spectrum Disorder (NMOSD)

Parkinson Disease (outpatient + chronic)

Peripheral Neuropathy (distal symmetric polyneuropathy — DSPN; acquired-causes screen)

Posterior Reversible Encephalopathy Syndrome (PRES)

Reversible Cerebral Vasoconstriction Syndrome (RCVS / Call-Fleming)

Restless Legs Syndrome / Willis–Ekbom Disease

Aneurysmal SAH — Good Grade (Hunt-Hess I–III)

Aneurysmal SAH — Poor Grade (Hunt-Hess IV–V)

Non-aneurysmal Perimesencephalic SAH

Subarachnoid Hemorrhage

Metastatic Spinal Cord Compression (MSCC)

Spinal Cord Infarction (Anterior Spinal Artery Syndrome and other vascular cord lesions)

Convulsive Status Epilepticus

Cardioembolic Stroke (TOAST CE)

Large-Artery Atherosclerotic Stroke (TOAST LAA)

Small-Vessel (Lacunar) Stroke (TOAST SVO)

Transient Ischemic Attack

Acute Transverse Myelitis

Trigeminal Neuralgia (classic / secondary / idiopathic)

Vascular Cognitive Impairment / Vascular Dementia

Acromegaly

Adrenal crisis

Cushing syndrome (endogenous + exogenous excluded)

Diabetes-related foot disease (ulcer, infection, osteomyelitis)

Diabetic ketoacidosis

Type 2 diabetes (chronic outpatient)

Hyperosmolar hyperglycemic state (adult)

Hyperparathyroidism (primary, secondary, tertiary)

Hyperprolactinaemia evaluation (exclude before prolactinoma)

Hyperthyroidism / thyrotoxicosis (Graves / toxic nodule / thyroiditis — standalone core)

Hypopituitarism

Hypothyroidism (overt / subclinical / central — standalone core)

Multiple endocrine neoplasia type 1 (MEN1)

Multiple endocrine neoplasia type 2A (MEN2A)

Multiple endocrine neoplasia type 2B (MEN2B)

Myxedema coma

Osteoporosis & fragility-fracture prevention (DXA/FRAX → treat-to-target)

Polycystic ovary syndrome (Rotterdam 2023 — dx, metabolic, fertility)

Pheochromocytoma / paraganglioma

Pituitary apoplexy

Primary aldosteronism (Conn syndrome)

Prolactinoma and hyperprolactinemia

Sheehan syndrome (postpartum hypopituitarism)

Type 1 diabetes (chronic outpatient — pediatric + adult)

Thyroid nodule evaluation (TI-RADS → FNA → Bethesda → management)

Thyroid storm

Anaemia of Chronic Disease / Anaemia of Inflammation (incl. anaemia of CKD, malignancy, chronic infection, functional iron deficiency)

Anticoagulation management

Aplastic Anaemia / Acquired Bone-Marrow Failure (SAA / vSAA — chronic + subacute)

Vitamin B12 & Folate Deficiency Anaemia (megaloblastic; pernicious anaemia + SCD)

Disseminated intravascular coagulation (DIC)

Haemolytic anaemia (AIHA / G6PD / hereditary spherocytosis — chronic + acute crisis)

Heparin-induced thrombocytopenia (HIT) — 4Ts + non-heparin anticoagulation

Iron-deficiency anaemia (chronic — adult / pediatric / pregnancy)

Immune Thrombocytopenia (chronic, outpatient)

Immune Thrombocytopenia (ITP) — initial diagnosis & acute Rx

Neutropenic Fever (Febrile Neutropenia)

Sickle Cell Disease (chronic management + acute crisis)

Thalassaemia (TDT / NTDT / α-thal-HbH / trait — chronic management)

Thrombotic Thrombocytopenic Purpura (immune-mediated)

Tumor Lysis Syndrome (TLS)

Venous thromboembolism — DVT + PE (diagnosis, anticoagulation, duration)

Acute Leukemia (AML / ALL / APL)

Multiple Myeloma (initial diagnosis + chronic management)

Breast cancer (core)

Colorectal cancer (core)

Immune-related adverse events (irAE) — checkpoint inhibitor toxicity management

Non-small cell lung cancer (NSCLC)

Bacterial meningitis (acute, community-acquired)

Candidemia / invasive candidiasis

Cellulitis & erysipelas

CMV disease + reactivation in immunocompromised hosts (HSCT / SOT / advanced HIV / biologic) — AST IDCOP 2019; ASBMT/IDSA HSCT; DHHS 2024 OI; Marty NEJM 2017 PMID 29211658

COVID-19 inpatient management

Catheter-related bloodstream infection (CRBSI / CLABSI)

Cryptococcal meningitis (HIV-associated and non-HIV)

CMV end-organ disease (pneumonia / colitis / retinitis / hepatitis / encephalitis) — Kotton Transplantation 2018 PMID 29596116 + Ljungman CID 2024 PMID 39041385 + Avery SOLSTICE CID 2022 PMID 34864943

Dengue (DENV-1/2/3/4) — without warning signs + with warning signs (critical phase) + severe dengue (DSS / bleeding / organ failure) + pregnancy + secondary heterologous infection + returning traveler differential + fluid overload recovery + vaccine decision (Dengvaxia seropositive-only / Qdenga any serostatus where approved)

Endemic mycoses (Histoplasmosis / Coccidioidomycosis / Blastomycosis / Paracoccidioidomycosis)

Infective endocarditis (native / prosthetic / CIED / right-sided)

Hepatitis C — initial evaluation & DAA

HIV — initial evaluation & rapid ART start

Pediatric Influenza

Influenza (acute)

Invasive aspergillosis

Lyme disease (early localized → late)

Malaria (uncomplicated + severe)

Measles (rubeola) — primary measles + pneumonia + ADEM + SSPE + atypical immunocompromised + immune amnesia + post-exposure prophylaxis + MMR vaccination eligibility

Necrotising fasciitis / Fournier’s gangrene / gas gangrene

Opportunistic infection overlay — HIV / transplant / biologic immunocompromise

Acute Osteomyelitis & Septic Arthritis

Pertussis (whooping cough) — Bordetella pertussis — catarrhal + paroxysmal + convalescent phases + infant pertussis (apnea, pneumonia, pulmonary hypertension) + adult atypical + post-exposure prophylaxis + maternal Tdap at 27-36 wk every pregnancy + DTaP/Tdap vaccination schedule + cocooning

Pneumocystis jirovecii pneumonia (PJP/PCP)

Acute pyelonephritis (uncomplicated → complicated)

Sepsis / septic shock

Drug-resistant tuberculosis (MDR / pre-XDR / XDR)

Pulmonary Tuberculosis (Drug-Susceptible)

Tetanus — generalized + localized + cephalic + neonatal forms + post-exposure prophylaxis (wound-stratified) + active Td/Tdap vaccination during convalescence

Toxic Shock Syndrome (Staphylococcal & Streptococcal)

Cerebral toxoplasmosis (HIV-associated and immunocompromised) — DHHS 2024 OI + Dannemann ACTG (Ann Intern Med 1992 PMID 1727093) + Katlama European RCT (CID 1996 PMID 8838183)

Varicella zoster virus disease — primary varicella + herpes zoster + PHN + complications + RZV vaccination eligibility

Tuberculosis (active drug-susceptible, MDR-TB, LTBI)

Necrotizing Soft-Tissue Infection

Fibromyalgia (ACR 2016 WPI/SSS; central sensitisation)

Acute gout flare (primary-care / ED — acute monoarthritis)

Chronic gout — urate-lowering therapy (treat-to-target)

Knee pain evaluation (Ottawa knee → OA / internal derangement / crystal / septic)

Low back pain (acute → subacute → chronic, primary-care)

Mechanical neck pain (axial / radicular / myelopathy / whiplash)

Osteoarthritis (knee / hip / hand — clinical dx → management)

Plantar heel pain (plantar fasciitis & mimics)

Shoulder pain / rotator-cuff disorders

Tendinopathy (Achilles / lateral elbow / patellar / gluteal / rotator-cuff overlap)

Axial spondyloarthritis

Eosinophilic granulomatosis with polyangiitis (EGPA)

Giant cell arteritis (GCA / temporal arteritis)

Gout (acute flare → urate-lowering therapy)

Granulomatosis with polyangiitis (GPA)

Idiopathic inflammatory myopathy (myositis)

Lupus nephritis

Microscopic polyangiitis (MPA)

Psoriatic arthritis

Rheumatoid arthritis

SLE flare (acute)

Systemic lupus erythematosus (chronic, treat-to-target)

Acne vulgaris (dermatology lens)

Actinic keratosis & keratinocyte carcinoma (BCC + cSCC, dermatology lens)

Alopecia areata (dermatology lens)

Atopic dermatitis (eczema)

Basal cell carcinoma

Bullous pemphigoid

Cellulitis & erysipelas (dermatology lens)

Contact dermatitis — allergic vs irritant (dermatology lens)

Cutaneous lupus erythematosus (ACLE / SCLE / discoid + variants)

Cutaneous T-cell lymphoma — mycosis fungoides & Sézary syndrome (dermatology lens)

Cutaneous drug eruption — morbilliform vs SCAR (dermatology lens)

Herpes zoster (shingles) — acute reactivation, complications & PHN

Hidradenitis suppurativa (acne inversa)

Lichen planus (dermatology lens)

Cutaneous melanoma (dermatology lens)

Pemphigus (vulgaris & foliaceus)

Pityriasis rosea

Prurigo nodularis (chronic nodular prurigo)

Plaque psoriasis (dermatology lens)

Pyoderma gangrenosum (neutrophilic ulcerative dermatosis)

Rosacea (dermatology lens)

Scabies — classic & crusted (Norwegian)

Seborrheic dermatitis (incl. dandruff + infantile cradle cap)

Stevens-Johnson syndrome / toxic epidermal necrolysis (SJS/TEN)

Cutaneous abscess / furuncle / carbuncle (I&D-primary purulent SSTI)

Cutaneous squamous cell carcinoma

Dermatophytosis / tinea (corporis, cruris, pedis, capitis, onychomycosis)

Urticaria (acute & chronic spontaneous/inducible)

Vitiligo (autoimmune depigmentation, dermatology lens)

Local Anesthetic Systemic Toxicity (LAST)

Malignant Hyperthermia Crisis

Preoperative Airway Evaluation and Difficult Airway Management

Burn management (acute resuscitation + transfer triage)

Post-cardiac-arrest care (ROSC bundle)

Mechanical Ventilation Management

Sepsis bridge (recognition + Hour-1 bundle)

Suspected fracture triage (decision rules + fragility-fracture loop)

Acute Extremity Compartment Syndrome

Pediatric bacterial meningitis

Neonatal HSV (SEM, CNS, disseminated forms) — empiric acyclovir + form-specific duration

Neonatal sepsis — early-onset (< 72 h) + late-onset (72 h - 28 d)

Pediatric sepsis / septic shock

Neonatal Early-Onset Sepsis (EOS)

Neonatal Hypoglycemia

Neonatal Hypoxic-Ischemic Encephalopathy (HIE)

Persistent Pulmonary Hypertension of the Newborn (PPHN)

Neonatal Respiratory Distress Syndrome (RDS)

Abusive head trauma / non-accidental trauma in infants

Pediatric acute kidney injury (AKI)

Acute appendicitis — pediatric (PAS-stratified; NOM-aware)

Biliary atresia

Pediatric bronchiolitis

Brief Resolved Unexplained Event (BRUE)

Pediatric community-acquired pneumonia (CAP)

Pediatric Croup (Laryngotracheobronchitis)

Pediatric diabetic ketoacidosis (DKA)

Pediatric Acute Epiglottitis (Supraglottitis)

Febrile infant (0-90 days)

Pediatric head injury / mild TBI / concussion (PECARN-stratified)

Neonatal hyperbilirubinemia — kernicterus prevention (AAP 2022 thresholds)

Infantile epileptic spasms syndrome (West syndrome)

Intussusception (ileocolic / ileoileal) — pediatric

Kawasaki disease

Intestinal malrotation with midgut volvulus

Multisystem inflammatory syndrome in children (MIS-C)

Necrotizing enterocolitis (NEC) — neonatal / preterm Bell-staged

Neonatal Abstinence Syndrome (NAS) / Neonatal Opioid Withdrawal Syndrome (NOWS)

Infantile hypertrophic pyloric stenosis (IHPS)

Reye syndrome

Pediatric status epilepticus

Pediatric toxic ingestions (acute)

Pediatric asthma (chronic stepwise + acute exacerbation)

Pediatric community-acquired pneumonia

Gestational diabetes (GDM)

Abnormal uterine bleeding (reproductive age — FIGO PALM-COEIN)

Bartholin gland cyst / abscess (I&D + Word catheter, marsupialization for recurrent)

Contraception management (US-MEC / US-SPR — method selection & comorbidity)

Dysmenorrhoea (primary vs secondary — endometriosis-aware)

Menopause & vasomotor-symptom management (MHT & non-hormonal)

Ovarian / adnexal torsion (time-critical surgical emergency)

Pelvic inflammatory disease (PID) + tubo-ovarian abscess (TOA)

Vaginitis (bacterial vaginosis / candidiasis / trichomoniasis)

Acute Fatty Liver of Pregnancy (AFLP)

Amniotic Fluid Embolism (AFE)

Breech Presentation at Term

Cervical Insufficiency (Painless 2nd-Trimester Cervical Dilation)

Chorioamnionitis / Intra-amniotic Infection (IAI) / Triple I

Ectopic pregnancy (tubal, interstitial, cornual, abdominal, cesarean-scar)

Gestational Diabetes Mellitus (A1 / A2 — OB perspective)

Gestational Hypertension (without severe features)

HELLP Syndrome (Hemolysis / Elevated Liver enzymes / Low Platelets)

Hyperemesis Gravidarum

Intrahepatic Cholestasis of Pregnancy (ICP)

Early Pregnancy Loss / Miscarriage

Peripartum Cardiomyopathy (PPCM)

Placenta Previa & Placenta Accreta Spectrum

Placental Abruption / Abruptio Placentae

Postpartum Hemorrhage (PPH)

Preterm Premature Rupture of Membranes (PPROM)

Pre-eclampsia / Eclampsia / HELLP

Pre-eclampsia, Early-Onset (< 34 weeks gestational age)

Preterm Labor (PTL) / Preterm Prelabor Rupture of Membranes (PPROM)

Shoulder Dystocia

Uterine Rupture (complete / incomplete dehiscence)

VTE in Pregnancy and Postpartum

Acute Drug-Induced Dystonia & Extrapyramidal Syndromes — acute dystonia (oculogyric crisis / torticollis / trismus / opisthotonos / LARYNGEAL DYSTONIA = airway emergency) vs acute akathisia vs drug-induced parkinsonism after dopamine-antagonist exposure; IV/IM anticholinergic (benztropine 1-2 mg or diphenhydramine 25-50 mg) reversal + airway management if laryngeal + offending-agent management + propranolol-first-line akathisia + parkinsonism dose-reduction; RULE OUT NMS / serotonin syndrome (Pierre Drug Saf 2005 PMID 16180939; van Harten BMJ 1999 PMID 10463905)

Attention-Deficit/Hyperactivity Disorder (ADHD) — chronic stepwise (AAP 2019 PMID 31570648; APA 2024; NICE NG87 2024; MTA 16-yr Hechtman PMID 30019501)

Acute Agitation / Behavioral Emergency (ED) — de-escalation-first + chemical restraint (PO if cooperative / IM if not / ketamine rescue) + parallel underlying-cause workup (POC glucose ALWAYS) + post-sedation monitoring (Project BETA AAEP 2012; ACEP 2024 clinical policy; ADEPT Wilson 2017 PMID 28856060)

Acute Alcohol Withdrawal — inpatient management

Anxiety Disorders (GAD / panic / social anxiety / specific phobia / agoraphobia) — chronic stepwise + acute panic (APA Panic 2009; NICE NG185 2024; CANMAT 2014 Katzman PMID 25081580)

Bipolar Disorder — acute mania + bipolar depression + maintenance (APA 2024; CANMAT/ISBD 2018; BALANCE Geddes Lancet 2010)

Catatonia — transdiagnostic syndrome; lorazepam challenge + titration → ECT for refractory / malignant (DSM-5-TR 2022; Bush 1996 PMID 8729911; Sienaert 2014 PMID 24523668)

Delirium — acute confusional state (DSM-5-TR 2022; SCCM PADIS 2018 PMID 30113379; NICE CG103 2010 reaffirmed 2024; CAM Inouye 2006 PMID 16540616; 4AT Bellelli 2014 PMID 25028342; MIND-USA Girard 2018 PMID 30346242)

Major Depressive Disorder (MDD) — chronic stepwise + acute crisis (APA 2023; VA/DoD 2022)

Eating Disorders (AN-R / AN-BP / BN / BED / ARFID / OSFED) — chronic stepwise + acute medical instability (APA 2023; AED 2016 Garber; NICE NG69 2023; Maudsley FBT Lock & Le Grange 2013; CBT-E Fairburn 2008)

First-Episode Psychosis (FEP) — medical workup + low-dose antipsychotic + CSC (APA 2024; RAISE-ETP Kane AJP 2016)

Neuroleptic Malignant Syndrome (NMS) — toxidrome from antipsychotic D2 blockade (Strawn AJP 2007 PMID 17541055; Levenson AJP 1985 PMID 2862613; DSM-5-TR 2022); STOP AP IMMEDIATELY + ICU + supportive (cooling + IV hydration) + dantrolene 1-2.5 mg/kg IV q6h + bromocriptine 2.5 mg PO TID + ECT for refractory; AVOID succinylcholine + re-introduction of offending AP + abrupt clozapine discontinuation

Acute OCD (Severe / Treatment-Resistant Exacerbation) — ED/inpatient acute stabilization + SRI high-dose + clomipramine adjunct + AP augmentation + ERP referral (APA OCD 2023; NICE CG31 2024; IOCDF 2025; PANS Consortium 2017 PMID 28859386)

Opioid Use Disorder — MOUD management

Postpartum depression — perinatal MDD (ACOG 757 2018/2024; USPSTF 2019; NICE NG192 2024; APA 2010 PPD; Meltzer-Brody 2018; Deligiannidis 2023)

Postpartum psychosis — acute postpartum psychiatric emergency (ACOG 757 2018/2024; NICE NG192 2024; APA 2024; Bergink 2012; Sit 2006)

PTSD (DSM-5-TR F43.10 acute / chronic / dissociative subtype + Acute Stress Disorder F43.0 + ICD-11 6B41 Complex PTSD) — trauma-focused psychotherapy first-line + SSRI/SNRI stepwise (APA 2017 PMID 28291938; VA/DoD 2023; NICE NG116 2024; ISTSS 2018)

Serotonin syndrome — toxidrome from serotonergic exposure (Hunter 2003 PMID 12925718; Boyer NEJM 2005 PMID 15784664); STOP serotonergic + benzo + cyproheptadine + cooling; severe → ICU + intubation + paralysis (rocuronium); AVOID bromocriptine + succinylcholine

Suicidality — ED risk assessment and disposition

Acetaminophen (paracetamol) overdose

Acute alcohol intoxication

Anticholinergic toxidrome

Beta-blocker overdose

Calcium channel blocker overdose

Carbon monoxide poisoning

Digoxin toxicity

Iron overdose

Lithium toxicity

Neuroleptic malignant syndrome

Acute opioid overdose

Organophosphate and carbamate poisoning

Salicylate (aspirin) overdose

Serotonin syndrome

Sympathomimetic toxidrome

Tricyclic antidepressant overdose

Toxic alcohols (methanol / ethylene glycol)

Benign Prostatic Hyperplasia (BPH) — chronic LUTS in adult men

Catheter-Associated UTI (CAUTI) — indwelling / suprapubic / intermittent / long-term

Acute epididymitis ± orchitis (STI / enteric / viral / TB / drug / torsion-pivot DDx)

Microscopic Hematuria Surveillance — chronic outpatient post-workup (AUA 2020 low / intermediate / high risk bands + IgA / Alport / sickle / anticoag / pediatric / schistosomiasis overlays)

Male Infertility Evaluation — chronic outpatient (azoospermia / oligospermia / asthenospermia / teratospermia / varicocele / HH / drug-induced / radiation)

Nocturia — chronic outpatient evaluation (nocturnal polyuria / reduced bladder capacity / 24-h polyuria / sleep / med / BPH / CHF / CKD / pregnancy / aging)

Pediatric Vesicoureteral Reflux (VUR) — grade I–V; primary / secondary / antenatal-hydronephrosis pathway; prophylaxis / surgical / behavioural management

Post-Prostatectomy Complications (post-RP + TURP) — bleeding / stricture / incontinence / ED / lymphocele / DVT-PE / rectal injury / TURP syndrome

Priapism — urological emergency (ischemic / non-ischemic / stuttering / SCD-driven / drug-induced)

Prostatitis spectrum (NIH I/II/IIIa/IIIb/IV) — acute bacterial + chronic + CP/CPPS

Acute pyelonephritis (upper UTI; outpatient + inpatient + complicated + urosepsis)

Recurrent UTI Prophylaxis & Long-term Management (adult women + postmenopausal + breakthrough)

Acute scrotal pain — pivot / triage workup (routes to torsion / epididymitis / Fournier / urolithiasis / appendix testis)

Testicular torsion (time-critical scrotal emergency, <6 h salvage window)

Urethral Stricture Disease (bulbar / penile / pan-urethral / LSA / iatrogenic / post-traumatic / pediatric / bladder-neck-contracture)

Urinary Incontinence — chronic outpatient evaluation (stress / urge / mixed / overflow / functional / continuous / pediatric / post-prostatectomy)

Urolithiasis (kidney / ureteral stones)

Complicated UTI (men, pregnant, catheter, anatomic, IC, ESBL/MDR, fungal, prostatitis overlay)

Pediatric UTI (neonate / infant / older child / adolescent; VUR, recurrent, dysfunctional voiding)

Uncomplicated UTI (acute cystitis, non-pregnant adult)

Acute Mesenteric Ischemia

Acute Limb Ischemia

Abdominal aortic aneurysm (surveillance + rupture)

Allergic rhinitis (seasonal + perennial)

Anaphylaxis (acute resuscitation)

IgE-mediated food allergy

Insect bites and stings (Hymenoptera, alpha-gal, non-Hymenoptera)

Mast cell activation syndrome (MCAS)

Postoperative Nausea and Vomiting

Acute rhinosinusitis (viral vs ABRS; complications)

Benign paroxysmal positional vertigo (with acute-vertigo triage)

Cerumen (earwax) impaction

Chronic rhinosinusitis (CRSsNP vs CRSwNP, biologic-era ladder, EPOS 2020 / AAO-HNS 2015)

Deep neck space infection (retropharyngeal / parapharyngeal / Ludwig — airway + sepsis triage, CT space-mapping, IV broad-spectrum ± surgical source control)

Acute epiglottitis / supraglottitis (airway-emergency triage, controlled airway, IV cephalosporin)

Epistaxis (anterior & posterior)

Ménière's disease (recurrent audiovestibular hydrops)

Acute otitis externa (incl. necrotizing/malignant OE)

Acute otitis media (ENT/EM lens)

Peritonsillar abscess (quinsy)

Acute pharyngitis & tonsillitis (Centor/McIsaac, GAS vs viral, airway-emergency triage)

Sudden sensorineural hearing loss (SSNHL — otologic emergency)

Chronic bothersome tinnitus (AAO-HNSF 2014 CPG — CBT first-line; AGAINST routine pharmacotherapy)

Temporomandibular disorders (DC/TMD axis-I/II — conservative-first; AGAINST irreversible occlusal therapy)

Recurrent tonsillitis & tonsillectomy candidacy (Paradise criteria, AAO-HNSF 2019 update)

Vestibular neuritis / acute labyrinthitis (acute vestibular syndrome, peripheral)

Delirium (older adult)

Alzheimer disease dementia

Dementia with Lewy bodies

Vascular dementia

Deprescribing in older adults

Falls in older adults

Frailty assessment and polypharmacy management

Pressure injury (staging and management)

Acute angle-closure glaucoma (AACG)

Acute conjunctivitis (viral / bacterial / allergic, with red-flag red-eye routing)

Acute red eye (undifferentiated triage)

Acute (sudden) vision loss — neuro-ophthalmology / EM triage

Age-related macular degeneration (dry, GA, and wet/neovascular)

Blepharitis, hordeolum (stye), and chalazion

Corneal abrasion & ocular-surface foreign body

Diabetic retinopathy and diabetic macular edema

Dry eye disease (aqueous-deficient and evaporative subtypes)

Endophthalmitis (intraocular infection)

Infectious keratitis (corneal ulcer)

Acute ocular trauma (open-globe / orbital emergency triage)

Primary open-angle glaucoma (POAG)

Optic neuritis — typical (demyelinating) vs atypical (NMOSD/MOGAD) neuro-ophthalmology lens

Orbital cellulitis (vs preseptal)

Preseptal (periorbital) cellulitis

Retinal detachment & acute PVD / retinal tear (vitreoretinal lens)

Subconjunctival haemorrhage

Uveitis (anterior / intermediate / posterior / panuveitis)

Adult immunization (preventive)

Preventive breast-cancer screening (adult)

Preventive cancer screening (adult)

Cervical cancer screening (adult)

Colorectal cancer screening (adult)

Lung cancer screening (LDCT, adult)

Abdominal pain (ED workup)

Acute / sudden vision loss

Altered mental status (ED workup — undifferentiated AMS)

Anemia symptom-triage (outpatient ddx + ED escalation for severe)

Acute back pain (ED red-flag workup)

Undifferentiated chest pain (ED)

Chronic constipation (outpatient symptom triage)

Acute cough (ED triage — undifferentiated adult)

Dementia / cognitive impairment

Acute diarrhea (ED triage — undifferentiated adult)

Undifferentiated dyspnea (ED)

Falls and fall risk (older adult)

Chronic fatigue (outpatient symptom triage)

Fever of unknown origin (FUO)

GI bleed (ED workup — upper + lower undifferentiated)

Hematuria (gross / microscopic)

Hemoptysis (massive / submassive / mild)

Hypercalcemia evaluation

Hyperkalemia symptom-triage (ED workup + cross-engine to syndrome)

Hyponatremia symptom-triage (ED workup + cross-engine to syndrome)

Jaundice (adult)

Leukocytosis symptom-triage (outpatient ddx + ED escalation for blasts / hyperleukocytosis)

Lymphadenopathy (localised / generalised / by location + features)

Acute nausea & vomiting (ED triage — undifferentiated adult)

Syncope (ED workup)

Thrombocytopenia symptom-triage (ED-primary; TTP/DIC/HIT/ITP/HELLP route + outpatient chronic)